Red Light Intervention on Myopic Progression

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

104 participants

Study Classification

INTERVENTIONAL

Study Start Date

2022-02-10

Study Completion Date

2024-06-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

To explore the effectiveness of using repeated low-level red-light therapy to slow myopia progression.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Red Light Intervention for Myopia Prevention

NCT04825769

Myopia

COMPLETED NA

The Effectiveness and Safety of Low-intensity Single-wavelength Red Light in Controlling High Myopia in Children and Adolescents：A Randomized, Controlled, Multicenter Clinical Trial

NCT05184621

Age 3 to 16 Years (Inclusive), Male or Female Clinical Diagnosis Confirming That Myopia Has Occurred in at Least One Eye The Guardian Voluntarily Signed the Subject's Informed Consent Form

COMPLETED NA

Efficacy of Repeated Low-Level Red-Light Therapy in Myopia Control

NCT04073238

Myopia Refractive Errors Eye Diseases

UNKNOWN NA

Minimum Power and Frequency of Repeated Low-level Red-light to Effectively Control Myopia Progression

NCT06717048

Myopia Refractive Error - Myopia Choroidal Thickness +1 more

RECRUITING NA

Fundus Effects of Repeated Low-Level Red-Light Therapy in Chinese Myopic Minors: A Randomized Controlled Clinical Trial

NCT06034912

Red Laser Light-Induced Retinopathy of Both Eyes (Diagnosis)

RECRUITING NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Myopia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Outcome Assessors

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Red Light Intervention

Repeated Low-Level Red-Light Therapy

Group Type EXPERIMENTAL

Red Light Intervention

Intervention Type DEVICE

Repeated Low-Level Red-Light Therapy

Low concentration atropine

0.01% atropine

Group Type ACTIVE_COMPARATOR

Atropine

Intervention Type DRUG

0.01% atropine

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Red Light Intervention

Repeated Low-Level Red-Light Therapy

Intervention Type DEVICE

Atropine

0.01% atropine

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Age at enrolment: 6-12 years;
2. At least one eye with spherical equivalent refractions (SERs): -1.00 to -5.00 diopters (D), and stigmatism of 1.50 D or less;
3. Anisometropia of 1.5 D or less;
4. The BCVA of distant vision is at least 0.8;
5. Myopia progressed more than 0.5D in the past year;
6. Have normal thinking and language communication skills, and be able to actively cooperate with the treatment as required;
7. Written informed consent of guardian and child.

Exclusion Criteria

1. Strabismus, amblyopia or other ocular abnormalities;
2. Other systemic abnormalities;
3. Prior treatment of myopia control in 6 months, e.g. drugs, orthokeratology, progressive addition lenses, bifocal lenses, etc in either eye;
4. Atropine allergy;
5. Other situations that not suitable for participating in the trial as judged by the researcher.

Minimum Eligible Age

6 Years

Maximum Eligible Age

12 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No